Abstract
White‐on‐white standard automated perimetry (SAP) is widely used in clinical and research settings for assessment of contrast sensitivity using incremental light stimuli across the visual field. It is one of the main functional measures of the effect of disease upon the visual system. SAP has evolved over the last 40 years to become an indispensable tool for comprehensive assessment of visual function. In modern clinical practice, a range of objective measurements of ocular structure, such as optical coherence tomography, have also become invaluable additions to the arsenal of the ophthalmic examination. Although structure‐function correlation is a highly desirable determinant of an unambiguous clinical picture for a patient, in practice, clinicians are often faced with discordance of structural and functional results, which presents them with a challenge. The construction principles behind the development of SAP are used to discuss the interpretation of visual fields, as well as the problem of structure‐function discordance. Through illustrative clinical examples, we provide useful insights to assist clinicians in combining a range of clinical results obtained from SAP and from advanced imaging techniques into a coherent picture that can help direct clinical management.
Keywords: Bloch's law, glaucoma, optical coherence tomography, perimetry, psychophysics, Ricco's law, spatial summation, structure‐function, temporal summation, tilted disc syndrome
The visual field broadly refers to the area in which a stimulus can be visually detected.1, 2 From the point of fixation, the monocular visual field of a normal human observer extends approximately 50 degrees superiorly, 70 degrees inferiorly, 60 degrees nasally and 100 degrees temporally.2, 3, 4 The visual field can be measured using a variety of perimetric techniques.5, 6 The extent and shape of the visual field varies with stimulus parameters, such as stimulus size.5, 6 In normal observers, kinetic perimetric thresholds coincide with the underlying spatial location of a static threshold obtained using the same stimulus size and luminance.7
In clinical practice, standard automated perimetry (SAP) is a common method of assessing the visual field,8, 9, 10 becoming increasingly popular in clinical practice and research settings since the 1970s and 1980s.11 As visual field results can provide clues regarding the location of the anomaly along the visual pathway, it is an instrumental component of the ocular and neurological examination;12, 13, 14, 15, 16, 17 however, recent studies have highlighted a number of problems with visual field testing in clinical practice. For example, the frequency of performing visual field assessment for diseases such as glaucoma is often not carried out uniformly across eye‐care practitioners.18, 19 There may also be structure‐function discordance within the examination results, whereby the defects found on structural measurements do not correlate well with SAP,20, 21 such as in pre‐perimetric22, 23 (also known as ‘mild’24) glaucoma. A number of models have been suggested to explain this discordance (reviewed in Malik, Swanson and Garway‐Heath25). Concurrently, there is increasing interest in objective, quicker and repeatable imaging techniques such as optical coherence tomography (OCT),26 which may help to obtain clinical data that do not rely on the subjective responses of the patient, particularly in the earlier stages of disease.27
This review paper contains a number of clinical examples of patients seen at the Centre for Eye Health28, 29, 30 to illustrate the role of visual field testing using SAP in a modern era of advanced imaging techniques. All patients had given their written informed consent for use of their anonymised results, with ethics approval given by the relevant University of New South Wales Human Research Ethics Committee. Research visual field results in the relevant figures were conducted in accordance with the tenets of the Declaration of Helsinki. Cases displaying structure‐function concordance and discordance are illustrated. Structure‐function discordance is put into the context of a number of construction, design and psychophysical principles behind SAP. A number of recent studies that have challenged current visual field testing paradigms are discussed, which may be promising in reconciling structure‐function discordance.
STANDARD AUTOMATED PERIMETRY IN CLINICAL PRACTICE
SAP is a non‐specific term used to describe any perimetric test measuring the detection threshold of a static, achromatic light stimulus of fixed size (Goldmann size III, GIII), presented for a fixed duration (approximately 100 to 200 ms) upon an achromatic background of constant luminance (1–10 cd/m2). Output measurements of SAP are typically provided using decibel (dB) scaled units, which are not measures of luminance intensity but rather of the attenuation of light from the instrument's density filters. A ‘high’ dB value means that the patient has responded to a highly attenuated – or dim – light stimulus. Output dB values are specific to the individual instrument, based on its maximum output stimulus and background luminance and hence, dB values are not directly comparable across SAP instruments.9, 31 Recent studies have provided conversion factors for dB into luminance values, based on instrument‐specific maximal and background luminances.5, 32
As SAP is widely used in clinical practice and research settings, it is often the reference for which other forms of perimetry are compared.15 Several different instruments have been devised which purportedly target different visual functions that may be affected in early disease.33, 34, 35, 36 There is debate as to whether certain types of retinal ganglion cell or visual pathways may37, 38, 39 or may not be40, 41, 42, 43, 44 differentially affected in early stages of disease. For example, new objective‐based techniques such as OCT,45, 46, 47 different forms of visual function assessment48, 49 and alternative SAP algorithms50, 51 have shown some promise in detecting deficits in visual functions other than contrast sensitivity thresholds, particularly in pre‐perimetric glaucoma. Although studies suggest that SAP may be relatively insensitive to early visual field changes in patients with disease, there exist no other widely accepted alternatives in clinical practice (see Jampel and colleagues15 for a full review). One of the key limitations of selective perimetry is the lack of evidence that specific and unique visual functions and pathways are tested.52
In clinical practice, the reliability of SAP results is affected by a range of factors, including those that are patient‐related. Modern thresholding algorithms have been developed to increase test efficiency and reduce patient fatigue (see McKendrick53 for a full review and select recent papers for newer algorithms54, 55, 56). The reliability of the visual field results can be assessed using four primary indices or some variation thereof: fixation losses, false positives, false negatives and the results of gaze tracking. The manufacturer of the SAP instrument often provides a cut‐off value for flagging a result as unreliable,8, 57 although such values in the literature are variable, ranging anywhere between 15 and 33 per cent.22, 58, 59, 60, 61, 62, 63 Inconsistencies have been suggested to be due to a range of factors, such as different patient populations, cultures, languages, educational backgrounds and understanding, visual field loss and technician ability, although these cut‐offs are also thought to be arbitrary.64
Patient attention and task understanding play important roles in test reliability, for example, to maintain fixation and to respond to very dimly seen stimuli, while refraining from responding to the absence of stimuli (Figure 1).65 There is a significant practice effect in performing visual fields. Errors from novice patients include inattention to latter parts of the test or trigger‐happy behaviour.8 Altered sensitivities in regions may alter the patient's ‘Hill of Vision’ and thus, erroneously flag adjacent points of normal or abnormal sensitivity (Figure 2).
False negatives may also be elevated in patients with visual field defects, due to irregular contrast sensitivity and sampling by the underlying retinal sensory elements and/or circuitry,66, 67, 68, 69 particularly when threshold sensitivities fall below certain levels.70, 71 False negative rates in patients with glaucomatous visual field loss may be as high as 42 per cent in glaucoma compared to less than 20 per cent expected in normal observers.66 Larger stimulus sizes (for example, Goldmann size V, GV) and the high luminance level at which the stimulus is presented at the blind spot may encroach upon the adjacent retinal regions and increase stray light, thereby elevating the proportion of apparent fixation losses.72, 73 Therefore, gaze trackers are useful, when paired with the proportion of fixation losses to determine if it is due to patient‐related factors of poor fixation or trigger‐happy behaviour or due to instrument‐related factors, such as stimulus size or incorrect initial blind spot mapping due to atypical disc physiology (Figure 2).74 Inconsistencies in visual field reliability indices are problematic for directly translating visual field results between studies and applying cut‐offs in clinical practice. As visual field testing is used for assessment of ocular and neurological diseases, further studies into the reliability characteristics of patients with different pathological conditions are required to determine optimum cut‐offs for accurate interpretation.
TEST PARAMETERS USED IN STANDARD AUTOMATED PERIMETRY
Background luminance and pupil size
The Humphrey Field Analyzer (HFA) and the recent Octopus perimeters (for example, Octopus 600 and 900) use a background luminance of 10 cd/m2, which renders the adaptive state of the eye to be within the low photopic range of vision. A relatively lower background luminance (for example, Octopus 101 model, 1.27 cd/m2 or the Medmont Perimeter, 3.2 cd/m2) can render the adaptive state of the eye to be within the high scotopic or mesopic range, depending upon pupil size. This is problematic because the cone and rod pathways have been shown to respond and interact differently to contrast, resulting in different perceptual experiences.75 Although relatively dimmer backgrounds have been suggested for examining patients with ocular disease with impaired dark adaptation,76, 77, 78 a lower background luminance means that some observers are tested within the non‐linear section of the threshold‐versus‐intensity (TVI) curve (the function relating contrast threshold and background luminance).79, 80, 81, 82 Testing within Weber's law, where contrast remains constant despite changes to background luminance requires approximately 100 Trolands (Td) of retinal illuminance.83, 84 This is important to eliminate the effects of background fluctuations in quanta, which may produce inconsistent threshold responses.79, 85 For example, within the mesopic adaptation range (the de Vries‐Rose section of the TVI curve) thresholds are related to the square root of background luminance and detection is limited by quantal fluctuations.86, 87 Due to the different sections of the TVI curve, pupil size is also an important consideration. A background luminance of 10 cd/m2 requires a pupil size of roughly 3.5 mm in diameter to meet the cut‐off of 100 Td to test within the Weber slope.83, 84 In comparison, a background luminance of 1.27 cd/m2 requires a pupil diameter of 10 mm.
A luminance within the low, rather than high, photopic range can be more comfortable for the patient and reduce artificial pupillary constriction. Decreases in retinal illumination can also be caused by media opacities, such as cataract, which produces a characteristic generalised reduction in sensitivity.88 It is recommended to maintain a consistent pupil size that renders adaptation within the Weber slope for visual field testing.
Stimulus size and duration: summation characteristics
Summation describes the ability of the eye to sum individual quanta of light over time (temporal) or over an area (spatial). The relationship between luminance, area and stimulus duration is expressed mathematically by: L.An1.tn2 = k (where L is the luminance of the stimulus, A is the stimulus area, t is the stimulus duration, n1 and n2 represent the spatial and temporal summation exponents, respectively, and k is a constant).89 From this equation, Ricco's law of spatial summation (L.An1 = k) and Bloch's law of temporal summation (L.tn2 = k) can be derived.90, 91 When n is equal to one, the test stimulus is operating within the critical area (Ac) or critical duration (Tc) of complete summation and there is a linear relationship between luminance and stimulus duration; outside of Tc or Ac, this relationship is non‐linear.5, 6, 92, 93, 94, 95, 96, 97
Although both size and duration are important considerations in perimetric testing, these are fixed in commercial standard automated perimetry. A brief stimulus presentation (100 to 200 ms in SAP) is below the minimum latency of a voluntary saccadic eye movement and above Bloch's critical duration of temporal summation (Tc).98 The standard GIII (diameter of 0.43 degrees) stimulus maximises the dynamic range of the instrument (by up to 12 dB in the periphery99), allows more reliable thresholds to be obtained compared to smaller sizes,5, 100, 101, 102, 103 and is less susceptible to blur.6, 104 A summary of Goldmann stimulus sizes available on the HFA is listed in Table 1.6, 105, 106
Table 1.
Several studies have suggested that use of a stimulus outside of Ac or Tc does not yield the maximum threshold elevation in a region affected by disease, in comparison to when a stimulus size is operating within complete summation.32, 94, 95, 97, 107 Although stimulus parameters used in SAP are said to be historical precedents,108 there are limitations in instrumentation109 and dynamic range110 that render the optimisation of size and duration an area of ongoing research.
TEST PATTERNS IN STANDARD AUTOMATED PERIMETRY
Early studies have suggested that the majority of significant visual field defects occur in the central 30 degrees from fixation.111, 112 Grid patterns examining this region eventually became widely used and standardised, such as the 10–2, 24–2 and 30–2 test grids on the HFA58, 59, 113, 114 (denoting the approximate extent of the visual field examined and the amount of spacing from the horizontal and vertical midlines8). Recent studies115, 116, 117 have examined the role of different test patterns and densities for a range of diseases; for example, use of the 10–2 pattern to sample the central visual field in glaucoma. For example, the 10–2 pattern has a finer point density compared to 24–2 and 30–2118, 119, 120 and is able to better sample the central papillomacular bundle. Points may be flagged as having reduced sensitivity using a typical 24–2 or 30–2 test grid with six degrees test point spacing, but the true extent of the defect may be missed unless a denser sampling grid, such as a 10–2 with two degrees point spacing, is used (Figure 3). This may be useful in certain types of glaucoma that have been suggested to show more progression in the central visual field,121 although whether or not the type of glaucoma is important for the location of defect is debated.122 Combinations of test patterns have also been suggested to achieve adequate test density123, 124 and customisation and sampling of specific regions of interest have been suggested to increase test efficiency.125, 126, 127, 128
THE STRUCTURE‐FUNCTION RELATIONSHIP IN VISUAL FIELD TESTING
Diseases affecting various regions along the visual pathway, from the retina up to the cortex, produce different types of visual field defect. Such defects are described by location (for example, centrocaecal, arcuate, quadrantonopia, hemianopia), by depth (relative or absolute scotoma), completeness (partial or full) and congruity (similarity between the two eyes). The monocular and binocular location of the defect can help determine the affected anatomical location. Generally, increasing congruity indicates a defect that is located in higher cortical areas. Therefore, visual field examination can localise structural deficits and determine the extent of underlying structural damage.
Ocular media
Global measurements of visual field sensitivity such as the mean deviation (MD) and total deviation (TD) map on the HFA can be affected by medial opacities.88 Common examples of these artefacts include dry eye and cataracts (Figure 4). Contact lenses can cause some artefacts due to dry eye or altered optical properties such as from multifocal lens designs.129 Such depressions are typically diffuse on the TD map and correlate with the location of the media opacity, although opacities that are sufficiently deep may also result in concurrent defects on the pattern deviation (PD) map.
Retinal pathology
Overt retinal diseases, such as retinal vascular occlusion or retinal degenerations, are typically accompanied by correlating functional defects in the visual field (Figure 5). The depth of the defect may depend on a range of factors, such as the extent of the underlying structural loss and the duration since onset. Advanced imaging techniques such as OCT can determine the extent of tissue loss and which retinal layers are affected. Separation or loss of certain retinal layers can give hints to whether a visual field defect is expected to be relative or absolute. Modalities such as autofluorescence and OCT angiography can also delineate the expected boundary of the visual field defect but subtle changes in vasculature have yet to yield significant130 structure‐function relationships, such as in glaucoma.131
When the extent of the visual field defect extends beyond the central retina or if small islands of vision are affected or spared in the periphery such as in retinitis pigmentosa, kinetic perimetry is likely to be better than SAP at measuring visual function.130, 132 Although some SAP instruments also include the ability to perform kinetic perimetry, such as the HFA‐3, the extent of the measurable visual field is still limited by instrument design (for example, up to 42 degrees superiorly for the HFA‐3).
Optic nerve pathology
Glaucoma uniquely offers the opportunity to examine the structure‐function relationship because of the way the retinal nerve fibre layer and optic nerve are affected at discrete locations. National bodies and guidelines recommend the use of SAP for diagnosis and monitoring of patients with glaucoma.15, 16 SAP results, commonly mean deviation values, are used for staging and monitoring for progression and hence, guidance of management (Figure 6).58, 133, 134 Typically, some variation of the 24–2 test pattern is used in conjunction with an adaptive thresholding algorithm, as it affords a balance of reducing variability (the more peripheral points used in the 30–2 pattern are excluded135), test time and fatigue,136, 137 while testing the nasal and central regions of interest, where glaucomatous defects commonly occur.138, 139 A variety of structure‐function maps are used in research settings140, 141 and are commercially available.142
In comparison to glaucoma and other ischaemic optic neuropathies, other optic diseases, such as inflammatory or compressive neuropathies, can affect different regions of the optic nerve and retinal nerve fibre layer and to varying degrees. Because of this, optic neuropathies such as optic neuritis, neuroretinitis and optic nerve head drusen may all present with different visual field defects.59, 143, 144, 145 Therefore, unlike glaucoma, these conditions sometimes do not have obvious structure‐function concordance, unless the region of optic nerve affected by disease is discrete, such as in optic disc pit (Figure 7). Using a 30–2 or similar visual field test grid is often recommended for examining these conditions due to the variability of extent of possible visual field defects.135
Beyond the retina and optic nerve
The anatomy of the optic chiasm and of the visual pathway beyond, means that, in general, visual field defects are bilateral.146 Patterns of visual field loss – pre‐chiasmal, chiasmal or post‐chiasmal – are useful for guiding subsequent neuroimaging.147, 148, 149
Chiasmal defects are characteristically bitemporal (Figure 8), with a bias toward either superior (for example, pituitary adenoma) or inferior (for example, craniopharyngioma) bitemporal defects, depending on aetiology.146, 150 Visual field losses in the far superotemporal and inferotemporal regions of the field may at first be subtle and the wider and symmetrical 30–2 test grid may be required.
One notable differential diagnosis for bitemporal defects is tilted disc syndrome, which may introduce relative myopic defocus (Figure 9).151 An additional myopic lens could be used for a repeat visual field test,151 which can reduce or eliminate this scotoma (Figure 9). Careful examination of the visual field sensitivity values can give clues as to the diagnosis, which may reduce the need and expense of further testing.
At the optic tract, visual field defects change from being symmetrical about the vertical axis to being homonymous and contralateral to the site of pathology, due to segregation of ipsilateral temporal (uncrossed) and contralateral nasal (crossed) retinal nerve fibre layer bundles. Optic tract and pre‐lateral geniculate nucleus defects tend to be relatively incongruous, due to incomplete pairing of the retinal nerve fibres from anatomically corresponding points in the visual field. In particular, unilateral defects along the optic tract manifest with a relative afferent pupillary defect on the contralateral side, due to asymmetric decussation of the pupillary fibres (approximately 54 to 67 per cent).152, 153 Defects higher along the visual pathway (for example, cortical lesions) are typically more congruous.154, 155
Lesions of the axons travelling in the optic radiations or cortical areas post‐lateral geniculate nucleus can give rise to trans‐synaptic retrograde degeneration of the retinal ganglion cells (see Zangerl and colleagues146 for a full review). Retrograde degeneration manifests as retinal nerve fibre layer or retinal ganglion cell loss mirroring the visual field defects that respect the vertical midline. Although these patterns are typically concordant with visual field findings, retinal nerve fibre layer and retinal ganglion cell changes on advanced imaging techniques, such as OCT or on optic nerve head examination can take time to develop.156 Instead, visual field testing may reveal definitive defects in the absence of significant structural loss (Figure 10).
THE PROBLEM OF STRUCTURE‐FUNCTION DISCORDANCE
Although there are typical visual field defects that occur with patterns of structural losses in disease, that is, structure‐function concordance, results in reality are often confounded by inherent variability of the measurement technique.17, 157, 158 This is especially true for diseases with slow progression or in the early stages of disease.159, 160, 161 As such, studies in ocular disease often list a requirement for demonstrated repeatable visual field loss, that is, not a reduction of sensitivity due to inherent variability, before classifying the presentation as true disease or progression of disease.58, 159, 161, 162
While glaucoma has been traditionally defined as an optic neuropathy with corresponding characteristic visual field loss, newer definitions note that statistically significant visual field losses, meeting the criteria set by published research papers, may not necessarily be present, in a stage known as ‘pre‐perimetric glaucoma’ (PPG) (or ‘mild’ glaucoma).24 In this case, there is structure‐function discordance, with overt structural deficits and absent visual field loss (Figure 11). PPG presents a diagnostic and management conundrum for clinicians. Waiting for progression prior to the initiation of treatment may mean the development of irreversible visual field loss, while over‐treatment of some patients may reduce overall quality of life.163 Although studies have shown that treatment reduces progression rates of patients with pre‐perimetric glaucoma, it is suggested that some patients progress so slowly that early treatment may not be indicated.22, 23
One of the most frequently quoted statements in ophthalmology164 is a variation upon: ‘at least 25 to 35 per cent retinal ganglion cell loss is associated with abnormalities in visual field testing’,20, 21 with the implication that SAP is relatively insensitive to the loss of neural tissue, accounting for PPG. This is now known to be an incorrect interpretation of the results.25, 165 Large clinical trials have shown a large variance in the number of patients reaching a visual field endpoint (35 to 86 per cent) for diagnosis or progression of glaucoma prior to the onset of structural change.58, 60, 62 One explanation for this difference is the endpoint definition. For example, the Ocular Hypertension Treatment Study (OHTS) had a visual field endpoint requiring a repeatable defect over three visits spanning six months, with a stringent inclusion criterion of requiring three reliable baseline visual field results.166 The European Glaucoma Prevention Study (EGPS) also required three visual field tests but these were spaced closer (within 30 days for confirmation), which may explain in part, why it had a greater proportion of patients reaching a functional endpoint.167 The Early Manifest Glaucoma Trial (EMGT) only required two defective visual field results to flag tentative progression, with a criterion that had a lower statistical threshold (three points at p < 0.05, rather than at least one with p < 0.01 in the OHTS).168 With less stringent visual field criteria compared to OHTS and EGPS, it follows that EMGT had a greater proportion of patients showing functional loss first.
Several reasons for discordance in the structure‐function relationship have been suggested, including proposals that SAP is relatively insensitive to early changes in the visual field, a ganglion cell reserve and redundancy20, 169, 170, 171 (see Malik, Swanson and Garway‐Heath25 for a review of structure‐function models). For example, the use of unequal units (linear versus logarithmic) has been a focal point for research in recent times.165 In this vein, there have been suggestions that due to the nature of the units of measurement, SAP is relatively insensitive to early functional loss because of its logarithmic change: it undergoes a relatively ‘flat’ or slow rate of change before manifesting more meaningful progression. Conversely, OCT imaging has been suggested to show more loss at the beginning but plateaus in advanced stages of disease due to the floor effect of its measurement technique (see Table 3 and Figure 4 in Medeiros and colleagues27). More recent studies have shown that equating for spatiotemporal summation characteristics can allow detection of functional losses in earlier stages of glaucoma.32, 94, 107 Simple modifications of test stimuli at different visual field test locations can specifically maximise defect detection, while maintaining the widest dynamic range of testing.32, 172 Defects found with such stimuli have been shown to be commensurate with underlying, detectable structural loss, thereby potentially improving the structure‐function relationship (Figures 12 and 13 and see Figure 4A in Kalloniatis and Khuu32).94, 107, 172 These studies highlight the shortcomings of using GIII or GV for detection of visual field defects, which have been suggested previously to maximise the dynamic range and reliability of testing:101, 110, 173 these relatively larger stimuli detect fewer and shallower defects compared to stimuli operating within complete spatial summation. More work is required to determine the optimal stimulus parameters that reveal the maximal threshold elevation in disease, while maximising the dynamic range of the instrument; however, it is likely that future test paradigms may modulate a variety of stimulus parameters, that is, not simply just contrast but also size and duration at various locations in the visual field.
Aside from the sensitivity of perimetric test stimuli, a number of questions remain unanswered. It is still not known whether current methods of measuring ocular structure are the most sensitive for correlating with functional loss, as there are suggestions that retinal ganglion cell dysfunction may contribute to patients with ‘pre‐structural glaucoma’ found using conventional examination techniques.174, 175 Methods of measuring retinal ganglion cell counts in humans in vivo have also been equivocal, showing large variation particularly in normal observers. For example, the position of the retinal nerve fibre layer raphe varies across individuals, which, in conjunction with relatively sparse visual field test grids, confound concordance of measurements.176 Individualised structure‐function mapping has been shown to be useful in improving structure‐function correlations but there still exists a range of variables, such as atypical disc appearances that are not accounted for by simple transposition of the OCT map.126, 177 It is possible that a combination of customised testing paradigms is required for optimal structure and function measurements for disease detection and monitoring for individual patients.126, 127, 177, 178
CONCLUSIONS
While modern technology has improved facets of visual field assessment using standard automated perimetry, the basic psychophysical task of detection of incremental light stimuli has remained virtually unchanged since the 1970s. There is a number of recognised limitations of standard automated perimetry but it remains the clinical standard of assessing the visual field. Recent research has challenged existing test paradigms. In combination with new computational techniques such as accompanying structural measurements, there is growing interest in reconciling the poor structure‐function relationship in early stages of disease. Preliminary results are promising in areas of research attempting to better reconcile the structure‐function relationship but more work is needed to produce a widespread paradigm shift in SAP.
ACKNOWLEDGEMENTS
Jack Phu was supported through a PhD scholarship provided by Guide Dogs NSW/ACT and an Australian Postgraduate Award PhD scholarship. This work was supported by the National Health and Medical Research Council of Australia (NHMRC #1033224). Guide Dogs NSW/ACT are partners in the NHMRC grant. The authors would like to thank the staff at the Centre for Eye Health for their clinical expertise in a number of these cases.
Professor Michael Kalloniatis and Dr Sieu K Khuu are named inventors on a patent involving the use of different Goldmann target sizes at different visual field locations for contrast sensitivity testing (International Publication Number WO 2014/094035 A1 (USA) and European Patent Number: 13865419.9). All other authors have no conflicts of interest and have no proprietary interest in any of the materials mentioned in this article.
REFERENCES
- 1. Traquair HM. An Introduction to Clinical Perimetry. London: Henry Kimpton, 1927. [Google Scholar]
- 2. Traquair HM. Clinical detection of early changes in the visual field. Trans Am Ophthalmol Soc 1939; 37: 158–179. [PMC free article] [PubMed] [Google Scholar]
- 3. Schiefer U, Patzold J, Dannheim F. [Conventional techniques of visual field examination Part 2: confrontation visual field testing ‐ kinetic perimetry]. Ophthalmologe 2005; 102: 821–827. [DOI] [PubMed] [Google Scholar]
- 4. Spector RH. Visual fields In: Walker HK, Wall WD, Hurst JW. eds. Clinical Methods: The History, Physical and Laboratory Examinations, 3rd edn. Boston: Butterworths, 1990. [PubMed] [Google Scholar]
- 5. Khuu SK, Kalloniatis M. Standard automated perimetry: determining spatial summation and its effect on contrast sensitivity across the visual field. Invest Ophthalmol Vis Sci 2015; 56: 3565–3576. [DOI] [PubMed] [Google Scholar]
- 6. Sloan LL. Area and luminance of test object as variables in examination of the visual field by projection perimetry. Vision Res 1961; 1: 121–138. [Google Scholar]
- 7. Phu J, Al‐Saleem N, Kalloniatis M et al. Physiologic statokinetic dissociation is eliminated by equating static and kinetic perimetry testing procedures. J Vis 2016; 16: 5. [DOI] [PubMed] [Google Scholar]
- 8. Heijl A, Patella VM. Essential Perimetry ‐ The Field Analyzer Primer. Dublin, California: Carl Zeiss Meditec, 2002. [Google Scholar]
- 9. Landers J, Sharma A, Goldberg I et al. Comparison of visual field sensitivities between the Medmont automated perimeter and the Humphrey field analyser. Clin Experiment Ophthalmol 2010; 38: 273–276. [DOI] [PubMed] [Google Scholar]
- 10. Rowe F. Visual Fields via the Visual Pathway. Boca Raton, Florida: CRC Press, 2016. [Google Scholar]
- 11. Johnson CA, Wall M, Thompson HS. A history of perimetry and visual field testing. Optom Vis Sci 2011; 88: E8‐E15. [DOI] [PubMed] [Google Scholar]
- 12. Anderson AJ, Shuey NH, Wall M. Rapid confrontation screening for peripheral visual field defects and extinction. Clin Exp Optom 2009; 92: 45–48. [DOI] [PubMed] [Google Scholar]
- 13. Classe JG. Legal aspects of visual field assessment. J Am Optom Assoc 1989; 60: 936–938. [PubMed] [Google Scholar]
- 14. Gutteridge IF. Should visual field examination be a routine part of ophthalmic practice? Doc Ophthalmol 1985; 59: 323–339. [DOI] [PubMed] [Google Scholar]
- 15. Jampel HD, Singh K, Lin SC et al. Assessment of visual function in glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology 2011; 118: 986–1002. [DOI] [PubMed] [Google Scholar]
- 16. NHMRC . Guidelines for the Screening, Prognosis, Diagnosis, Management and Prevention of Glaucoma. Canberra, Australia, 2010. [Google Scholar]
- 17. Turpin A, McKendrick AM, Johnson CA et al. Properties of perimetric threshold estimates from full threshold, ZEST and SITA‐like strategies, as determined by computer simulation. Invest Ophthalmol Vis Sci 2003; 44: 4787–4795. [DOI] [PubMed] [Google Scholar]
- 18. Malik R, Baker H, Russell RA et al. A survey of attitudes of glaucoma subspecialists in England and Wales to visual field test intervals in relation to NICE guidelines. BMJ Open 2013; 3: e002067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Fung SS, Lemer C, Russell RA et al. Are practical recommendations practiced? A national multi‐centre cross‐sectional study on frequency of visual field testing in glaucoma. Br J Ophthalmol 2013; 97: 843–847. [DOI] [PubMed] [Google Scholar]
- 20. Kerrigan‐Baumrind LA, Quigley HA, Pease ME et al. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci 2000; 41: 741–748. [PubMed] [Google Scholar]
- 21. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol 1989; 107: 453–464. [DOI] [PubMed] [Google Scholar]
- 22. Jeong JH, Park KH, Jeoung JW et al. Preperimetric normal tension glaucoma study: long‐term clinical course and effect of therapeutic lowering of intraocular pressure. Acta Ophthalmol 2014; 92: e185–193. [DOI] [PubMed] [Google Scholar]
- 23. Kim KE, Jeoung JW, Kim DM et al. Long‐term follow‐up in preperimetric open‐angle glaucoma: progression rates and associated factors. Am J Ophthamol 2015; 159: 160–168. [DOI] [PubMed] [Google Scholar]
- 24. Prum BE, Jr. , Rosenberg LF, Gedde SJ et al. Primary open‐angle glaucoma preferred practice pattern® guidelines. Ophthalmology 2016; 123: P41–P111. [DOI] [PubMed] [Google Scholar]
- 25. Malik R, Swanson WH, Garway‐Heath DF. ‘Structure‐function relationship’ in glaucoma: past thinking and current concepts. Clin Experiment Ophthalmol 2012; 40: 369–380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Elam AR, Blachley TS, Stein JD. Geographic variation in the use of diagnostic testing of patients with newly diagnosed open‐angle glaucoma. Ophthalmology 2016; 123: 522–531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Medeiros FA, Zangwill L, Bowd C et al. The structure and function relationship in glaucoma: implications for detection of progression and measurement of rates of change. Invest Ophthalmol Vis Sci 2012; 53: 6939–6946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Jamous KF, Jalbert I, Kalloniatis M et al. Australian optometric and ophthalmologic referral pathways for people with age‐related macular degeneration, diabetic retinopathy and glaucoma. Clin Exp Optom 2014; 97: 248–255. [DOI] [PubMed] [Google Scholar]
- 29. Jamous KF, Kalloniatis M, Hennessy MP et al. Clinical model assisting with the collaborative care of glaucoma patients and suspects. Clin Experiment Ophthalmol 2015; 43: 308–319. [DOI] [PubMed] [Google Scholar]
- 30. Yoshioka N, Wong E, Kalloniatis M et al. Influence of education and diagnostic modes on glaucoma assessment by optometrists. Ophthalmic Physiol Opt 2015; 35: 682–698. [DOI] [PubMed] [Google Scholar]
- 31. Pye D, Herse P, Nguyen H et al. Conversion factor for comparison of data from Humphrey and Medmont automated perimeters. Clin Exp Optom 1999; 82: 11–14. [DOI] [PubMed] [Google Scholar]
- 32. Kalloniatis M, Khuu SK. Equating spatial summation in visual field testing reveals greater loss in optic nerve disease. Ophthalmic Physiol Opt 2016; 36: 439–452. [DOI] [PubMed] [Google Scholar]
- 33. Sakata LM, DeLeon‐Ortega J, Girkin CA. Selective perimetry in glaucoma diagnosis. Curr Opin Ophthalmol 2007; 18: 115–121. [DOI] [PubMed] [Google Scholar]
- 34. Sample PA, Bosworth CF, Blumenthal EZ et al. Visual function‐specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. Invest Ophthalmol Vis Sci 2000; 41: 1783–1790. [PubMed] [Google Scholar]
- 35. Sample PA, Madrid ME, Weinreb RN. Evidence for a variety of functional defects in glaucoma‐suspect eyes. J Glaucoma 1994; 3 (Suppl 1): S5‐S18. [PubMed] [Google Scholar]
- 36. Sample PA, Medeiros FA, Racette L et al. Identifying glaucomatous vision loss with visual‐function‐specific perimetry in the diagnostic innovations in glaucoma study. Invest Ophthalmol Vis Sci 2006; 47: 3381–3389. [DOI] [PubMed] [Google Scholar]
- 37. Glovinsky Y, Quigley HA, Dunkelberger GR. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci 1991; 32: 484–491. [PubMed] [Google Scholar]
- 38. Quigley HA, Dunkelberger GR, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology 1988; 95: 357–363. [DOI] [PubMed] [Google Scholar]
- 39. Quigley HA, Sanchez RM, Dunkelberger GR et al. Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci 1987; 28: 913–920. [PubMed] [Google Scholar]
- 40. Morgan JE. Selective cell death in glaucoma: does it really occur? Br J Ophthalmol 1994; 78: 875–880. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Morgan JE. Retinal ganglion cell shrinkage in glaucoma. J Glaucoma 2002; 11: 365–370. [DOI] [PubMed] [Google Scholar]
- 42. Morgan JE, Uchida H, Caprioli J. Retinal ganglion cell death in experimental glaucoma. Br J Ophthalmol 2000; 84: 303–310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Yücel YH, Zhang Q, Gupta N et al. Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol 2000; 118: 378–384. [DOI] [PubMed] [Google Scholar]
- 44. Yücel YH, Zhang Q, Weinreb RN et al. Effects of retinal ganglion cell loss on magno‐, parvo‐, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res 2003; 22: 465–481. [DOI] [PubMed] [Google Scholar]
- 45. Kanamori A, Nagai‐Kusuhara A, Escano MF et al. Comparison of confocal scanning laser ophthalmoscopy, scanning laser polarimetry and optical coherence tomography to discriminate ocular hypertension and glaucoma at an early stage. Graefes Arch Clin Exp Ophthalmol 2006; 244: 58–68. [DOI] [PubMed] [Google Scholar]
- 46. Lisboa R, Leite MT, Zangwill LM et al. Diagnosing preperimetric glaucoma with spectral domain optical coherence tomography. Ophthalmology 2012; 119: 2261–2269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Mardin CY, Horn FK, Jonas JB et al. Preperimetric glaucoma diagnosis by confocal scanning laser tomography of the optic disc. Br J Ophthalmol 1999; 83: 299–304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Adhikari P, Zele AJ, Thomas R et al. Quadrant field pupillometry detects melanopsin dysfunction in glaucoma suspects and early glaucoma. Sci Rep 2016; 6: 33373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Wen W, Zhang P, Liu T et al. A novel motion‐on‐color paradigm for isolating magnocellular pathway function in preperimetric glaucoma. Invest Ophthalmol Vis Sci 2015; 56: 4439–4446. [DOI] [PubMed] [Google Scholar]
- 50. Asaoka R, Iwase A, Hirasawa K et al. Identifying ‘preperimetric’ glaucoma in standard automated perimetry visual fields. Invest Ophthalmol Vis Sci 2014; 55: 7814–7820. [DOI] [PubMed] [Google Scholar]
- 51. Asaoka R, Murata H, Iwase A et al. Detecting preperimetric glaucoma with standard automated perimetry using a deep learning classifier. Ophthalmology 2016; 123: 1974–1980. [DOI] [PubMed] [Google Scholar]
- 52. Casson EJ, Johnson CA, Shapiro LR. Longitudinal comparison of temporal‐modulation perimetry with white‐on‐white and blue‐on‐yellow perimetry in ocular hypertension and early glaucoma. J Opt Soc Am A 1993; 10: 1792–1806. [DOI] [PubMed] [Google Scholar]
- 53. McKendrick AM. Recent developments in perimetry: test stimuli and procedures. Clin Exp Optom 2005; 88: 73–80. [DOI] [PubMed] [Google Scholar]
- 54. Luithardt AF, Meisner C, Monhart M et al. Validation of a new static perimetric thresholding strategy (GATE). Br J Ophthalmol 2015; 99: 11–15. [DOI] [PubMed] [Google Scholar]
- 55. Denniss J, McKendrick AM, Turpin A. Towards patient‐tailored perimetry: automated perimetry can be improved by seeding procedures with patient‐specific structural information. Transl Vis Sci Technol 2013; 2: 3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Rubinstein NJ, McKendrick AM, Turpin A. Incorporating spatial models in visual field test procedures. Transl Vis Sci Technol 2016; 5: 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Rao HL, Yadav RK, Begum VU et al. Role of visual field reliability indices in ruling out glaucoma. JAMA Ophthalmol 2015; 133: 40–44. [DOI] [PubMed] [Google Scholar]
- 58. Kass MA, Heuer DK, Higginbotham EJ et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open‐angle glaucoma. Arch Ophthalmol 2002; 120: 701–713. [DOI] [PubMed] [Google Scholar]
- 59. Keltner JL, Johnson CA, Spurr JO et al. Baseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trial. Optic Neuritis Study Group. Arch Ophthalmol 1993; 111: 231–234. [DOI] [PubMed] [Google Scholar]
- 60. Leske MC, Heijl A, Hussein M et al. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 2003; 121: 48–56. [DOI] [PubMed] [Google Scholar]
- 61. Garway‐Heath DF, Crabb DP, Bunce C et al. Latanoprost for open‐angle glaucoma (UKGTS): a randomised, multicentre, placebo‐controlled trial. Lancet 2015; 385: 1295–1304. [DOI] [PubMed] [Google Scholar]
- 62. Miglior S, Zeyen T, Pfeiffer N et al. Results of the European Glaucoma Prevention Study. Ophthalmology 2005; 112: 366–375. [DOI] [PubMed] [Google Scholar]
- 63. Krupin T, Liebmann JM, Greenfield DS et al. The Low‐pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients. Ophthalmology 2005; 112: 376–385. [DOI] [PubMed] [Google Scholar]
- 64. Birt CM, Shin DH, Samudrala V et al. Analysis of reliability indices from Humphrey visual field tests in an urban glaucoma population. Ophthalmology 1997; 104: 1126–1130. [DOI] [PubMed] [Google Scholar]
- 65. Henson DB, Emuh T. Monitoring vigilance during perimetry by using pupillography. Invest Ophthalmol Vis Sci 2010; 51: 3540–3543. [DOI] [PubMed] [Google Scholar]
- 66. Bengtsson B, Heijl A. False‐negative responses in glaucoma perimetry: indicators of patient performance or test reliability? Invest Ophthalmol Vis Sci 2000; 41: 2201–2204. [PubMed] [Google Scholar]
- 67. Katz J, Sommer A. Reliability indexes of automated perimetric tests. Arch Ophthalmol 1988; 106: 1252–1254. [DOI] [PubMed] [Google Scholar]
- 68. Katz J, Sommer A. Screening for glaucomatous visual field loss. The effect of patient reliability. Ophthalmology 1990; 97: 1032–1037. [DOI] [PubMed] [Google Scholar]
- 69. Katz J, Sommer A, Witt K. Reliability of visual field results over repeated testing. Ophthalmology 1991; 98: 70–75. [DOI] [PubMed] [Google Scholar]
- 70. Gardiner SK, Swanson WH, Demirel S. The effect of limiting the range of perimetric sensitivities on pointwise assessment of visual field progression in glaucoma. Invest Ophthalmol Vis Sci 2016; 57: 288–294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Gardiner SK, Swanson WH, Goren D et al. Assessment of the reliability of standard automated perimetry in regions of glaucomatous damage. Ophthalmology 2014; 121: 1359–1369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Fankhauser F. Re: The influence of stimulus size on perimetric detection of small scotomata by Toke Bek and Henrik Lund‐Andersen. Graefes Arch Clin Exp Ophthalmol 1990; 228: 383–384. [DOI] [PubMed] [Google Scholar]
- 73. Bek T, Lund‐Andersen H. The influence of stimulus size on perimetric detection of small scotomata. Graefes Arch Clin Exp Ophthalmol 1989; 227: 531–534. [DOI] [PubMed] [Google Scholar]
- 74. Sanabria O, Feuer WJ, Anderson DR. Pseudo‐loss of fixation in automated perimetry. Ophthalmology 1991; 98: 76–78. [DOI] [PubMed] [Google Scholar]
- 75. Zele AJ, Cao D. Vision under mesopic and scotopic illumination. Front Psychol 2014; 5: 1594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Herse P. An application of threshold‐versus‐intensity functions in automated static perimetry. Vision Res 2005; 45: 461–468. [DOI] [PubMed] [Google Scholar]
- 77. Kalloniatis M, Harwerth RS, Smith EL 3rd et al. Colour vision anomalies following experimental glaucoma in monkeys. Ophthalmic Physiol Opt 1993; 13: 56–67. [DOI] [PubMed] [Google Scholar]
- 78. Owsley C, McGwin G Jr, Clark ME et al. Delayed rod‐mediated dark adaptation is a functional biomarker for incident early age‐related macular degeneration. Ophthalmology 2016; 123: 344–351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79. Barlow HB. Increment thresholds at low intensities considered as signal/noise discriminations. J Physiol 1957; 136: 469–488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Davson H. Physiology of the Eye, 5th Ed. London: Macmillan Academic and Professional Ltd, 1990. [Google Scholar]
- 81. Kalloniatis M, Harwerth RS. Spectral sensitivity and adaptation characteristics of cone mechanisms under white‐light adaptation. J Opt Soc Am A 1990; 7: 1912–1928. [DOI] [PubMed] [Google Scholar]
- 82. Kalloniatis M, Harwerth RS. Effects of chromatic adaptation on opponent interactions in monkey increment‐threshold spectral‐sensitivity functions. J Opt Soc Am A 1991; 8: 1818–1831. [DOI] [PubMed] [Google Scholar]
- 83. Boynton RM, Whitten DN. Visual adaptation in monkey cones: recordings of late receptor potentials. Science 1970; 170: 1423–1426. [DOI] [PubMed] [Google Scholar]
- 84. Whittle P, Challands PD. The effect of background luminance on the brightness of flashes. Vision Res 1969; 9: 1095–1110. [DOI] [PubMed] [Google Scholar]
- 85. Hecht S. The visual discrimination of intensity and the Weber‐Fechner law. J Gen Physiol 1924; 7: 235–267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Rose A. The sensitivity performance of the human eye on an absolute scale. J Opt Soc Am 1948; 38: 196–208. [DOI] [PubMed] [Google Scholar]
- 87. Brown LG, Rudd ME. Evidence for a noise gain control mechanism in human vision. Vision Res 1998; 38: 1925–1933. [DOI] [PubMed] [Google Scholar]
- 88. Heuer DK, Anderson DR, Feuer WJ et al. The influence of decreased retinal illumination on automated perimetric threshold measurements. Am J Ophthamol 1989; 108: 643–650. [DOI] [PubMed] [Google Scholar]
- 89. Owen WG. Spatio‐temporal integration in the human peripheral retina. Vision Res 1972; 12: 1011–1026. [DOI] [PubMed] [Google Scholar]
- 90. Graham CH, Margaria R. Area and the intensity‐time relation in the peripheral retina. Am J Physiol 1935; 113: 299–305. [Google Scholar]
- 91. Ricco A. Relazione fra il minimo angolo visuale e l'intensita luminosa. [Relationship between the minimum visual angle and intensity of light]. Annali di Ottalmologia 1877; 6: 373–479. [Google Scholar]
- 92. Baumgardt E. Threshold quantal problems In: Jameson D, Hurvich LM. eds. Visual Psychophysics. New York: Springer Berlin Heidelberg, 1972. p 29–55. [Google Scholar]
- 93. Khuu SK, Kalloniatis M. Spatial summation across the central visual field: implications for visual field testing. J Vis 2015; 15: 15.1.6. [DOI] [PubMed] [Google Scholar]
- 94. Mulholland PJ, Redmond T, Garway‐Heath DF et al. Spatiotemporal Summation of Perimetric Stimuli in Early Glaucoma. Invest Ophthalmol Vis Sci 2015; 56: 6473–6482. [DOI] [PubMed] [Google Scholar]
- 95. Sloan LL, Brown DJ. Area and luminance of test object as variables in projection perimetry ‐ clinical studies of photometric dysharmony. Vision Res 1962; 2: 527–541. [Google Scholar]
- 96. Wilson ME. Spatial and temporal summation in impaired regions of the visual field. J Physiol 1967; 189: 189–208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97. Wilson ME. Invariant features of spatial summation with changing locus in the visual field. J Physiol 1970; 207: 611–622. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98. Mulholland PJ, Redmond T, Garway‐Heath DF et al. The effect of age on the temporal summation of achromatic perimetric stimuli. Invest Ophthalmol Vis Sci 2015; 56: 6467–6472. [DOI] [PubMed] [Google Scholar]
- 99. Fankhauser F. Problems related to the design of automatic perimeters. Doc Ophthalmol 1979; 47: 89–139. [DOI] [PubMed] [Google Scholar]
- 100. Choplin NT, Sherwood MB, Spaeth GL. The effect of stimulus size on the measured threshold values in automated perimetry. Ophthalmology 1990; 97: 371–374. [DOI] [PubMed] [Google Scholar]
- 101. Wall M, Kutzko KE, Chauhan BC. Variability in patients with glaucomatous visual field damage is reduced using size V stimuli. Invest Ophthalmol Vis Sci 1997; 38: 426–435. [PubMed] [Google Scholar]
- 102. Wilensky JT, Mermelstein JR, Siegel HG. The use of different‐sized stimuli in automated perimetry. Am J Ophthamol 1986; 101: 710–713. [DOI] [PubMed] [Google Scholar]
- 103. Gilpin LB, Stewart WC, Hunt HH et al. Threshold variability using different Goldmann stimulus sizes. Acta Ophthalmol (Copenh) 1990; 68: 674–676. [DOI] [PubMed] [Google Scholar]
- 104. Fankhauser F, Enoch JM. The effects of blur upon perimetric thresholds. A method for determining a quantitative estimate of retinal contour. Arch Ophthalmol 1962; 68: 240–251. [DOI] [PubMed] [Google Scholar]
- 105. ISO . International Standard: Ophthalmic instruments ‐ perimeters. ISO 12866:1999. Geneva, Switzerland, 1999. [Google Scholar]
- 106. ISO . International Standard: Ophthalmic instruments ‐ perimeters. ISO 12866:1999/Amd.1:2008(E). Geneva, Switzerland, 2008.
- 107. Redmond T, Garway‐Heath DF, Zlatkova MB et al. Sensitivity loss in early glaucoma can be mapped to an enlargement of the area of complete spatial summation. Invest Ophthalmol Vis Sci 2010; 51: 6540–6548. [DOI] [PubMed] [Google Scholar]
- 108. Swanson WH. Stimulus size for perimetry in patients with glaucoma. Invest Ophthalmol Vis Sci 2013; 54: 3984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109. Heijl A. The Humphrey Field Analyzer, construction and concepts In: Heijl AG, Samander C. eds. Sixth International Visual Field Symposium: Springer Netherlands, 1985. pp 77–84. [Google Scholar]
- 110. Wall M, Woodward KR, Doyle CK et al. The effective dynamic ranges of standard automated perimetry sizes III and V and motion and matrix perimetry. Arch Ophthalmol 2010; 128: 570–576. [DOI] [PubMed] [Google Scholar]
- 111. Caprioli J, Spaeth GL. Static threshold examination of the peripheral nasal visual field in glaucoma. Arch Ophthalmol 1985; 103: 1150–1154. [DOI] [PubMed] [Google Scholar]
- 112. Werner EB, Drance SM. Early visual field disturbances in glaucoma. Arch Ophthalmol 1977; 95: 1173–1175. [DOI] [PubMed] [Google Scholar]
- 113. Marmor MF, Kellner U, Lai TY et al. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 2011; 118: 415–422. [DOI] [PubMed] [Google Scholar]
- 114. Choi AY, Nivison‐Smith L, Khuu SK et al. Determining spatial summation and its effect on contrast sensitivity across the central 20 degrees of visual field. PLoS ONE 2016; 11: e0158263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115. Asaoka R. Mapping glaucoma patients’ 30–2 and 10–2 visual fields reveals clusters of test points damaged in the 10–2 grid that are not sampled in the sparse 30–2 grid. PLoS ONE 2014; 9: e98525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116. Hood DC, Raza AS, de Moraes CG et al. Initial arcuate defects within the central 10 degrees in glaucoma. Invest Ophthalmol Vis Sci 2011; 52: 940–946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117. Park SC, Kung Y, Su D et al. Parafoveal scotoma progression in glaucoma: humphrey 10–2 versus 24–2 visual field analysis. Ophthalmology 2013; 120: 1546–1550. [DOI] [PubMed] [Google Scholar]
- 118. Heijl A. Perimetric point density and detection of glaucomatous visual field loss. Acta Ophthalmol 1993; 71: 445–450. [DOI] [PubMed] [Google Scholar]
- 119. Henson DB, Chauhan BC, Hobley A. Screening for glaucomatous visual field defects: the relationship between sensitivity, specificity and the number of test locations. Ophthalmic Physiol Opt 1988; 8: 123–127. [DOI] [PubMed] [Google Scholar]
- 120. King D, Drance SM, Douglas GR et al. The detection of paracentral scotomas with varying grids in computed perimetry. Arch Ophthalmol 1986; 104: 524–525. [DOI] [PubMed] [Google Scholar]
- 121. Ahrlich KG, De Moraes CG, Teng CC et al. Visual field progression differences between normal‐tension and exfoliative high‐tension glaucoma. Invest Ophthalmol Vis Sci 2010; 51: 1458–1463. [DOI] [PubMed] [Google Scholar]
- 122. Cho HK, Lee J, Lee M et al. Initial central scotomas vs peripheral scotomas in normal‐tension glaucoma: clinical characteristics and progression rates. Eye 2014; 28: 303–311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123. Ehrlich AC, Raza AS, Ritch R et al. Modifying the conventional visual field test pattern to improve the detection of early glaucomatous defects in the central 10 degrees. Transl Vis Sci Technol 2014; 3: 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124. Hood DC, Nguyen M, Ehrlich AC et al. A test of a model of glaucomatous damage of the macula with high‐density perimetry: implications for the locations of visual field test points. Transl Vis Sci Technol 2014; 3: 5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125. Aoyama Y, Murata H, Tahara M et al. A method to measure visual field sensitivity at the edges of glaucomatous scotomata. Invest Ophthalmol Vis Sci 2014; 55: 2584–2591. [DOI] [PubMed] [Google Scholar]
- 126. Chong LX, McKendrick AM, Ganeshrao SB et al. Customized, automated stimulus location choice for assessment of visual field defects. Invest Ophthalmol Vis Sci 2014; 55: 3265–3274. [DOI] [PubMed] [Google Scholar]
- 127. Chong LX, Turpin A, McKendrick AM. Targeted spatial sampling using GOANNA improves detection of visual field progression. Ophthalmic Physiol Opt 2015; 35: 155–169. [DOI] [PubMed] [Google Scholar]
- 128. Denniss J, McKendrick AM, Turpin A. An anatomically customizable computational model relating the visual field to the optic nerve head in individual eyes. Invest Ophthalmol Vis Sci 2012; 53: 6981–6990. [DOI] [PubMed] [Google Scholar]
- 129. Madrid‐Costa D, Ruiz‐Alcocer J, García‐Lázaro S et al. Effect of multizone refractive multifocal contact lenses on standard automated perimetry. Eye Contact Lens 2012; 38: 278–271. [DOI] [PubMed] [Google Scholar]
- 130. Ogura S, Yasukawa T, Kato A et al. Wide‐field fundus autofluorescence imaging to evaluate retinal function in patients with retinitis pigmentosa. Am J Ophthamol 2014; 158: 1093–1098. [DOI] [PubMed] [Google Scholar]
- 131. Liu L, Jia Y, Takusagawa HL et al. Optical coherence tomography angiography of the peripapillary retina in glaucoma. JAMA Ophthalmol 2015; 133: 1045–1052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132. Oishi A, Ogino K, Makiyama Y et al. Wide‐field fundus autofluorescence imaging of retinitis pigmentosa. Ophthalmology 2013; 120: 1827–1834. [DOI] [PubMed] [Google Scholar]
- 133. Mills RP, Budenz DL, Lee PP et al. Categorizing the stage of glaucoma from pre‐diagnosis to end‐stage disease. Am J Ophthamol 2006; 141: 24–30. [DOI] [PubMed] [Google Scholar]
- 134. Artes PH, Nicolela MT, LeBlanc RP et al. Visual field progression in glaucoma: total versus pattern deviation analyses. Invest Ophthalmol Vis Sci 2005; 46: 4600–4606. [DOI] [PubMed] [Google Scholar]
- 135. Khoury JM, Donahue SP, Lavin PJ et al. Comparison of 24–2 and 30–2 perimetry in glaucomatous and nonglaucomatous optic neuropathies. J Neuroophthalmol 1999; 19: 100–108. [PubMed] [Google Scholar]
- 136. Fingeret M. Clinical alternative for reducing the time needed to perform automated threshold perimetry. J Am Opt Assoc 1995; 66: 699–705. [PubMed] [Google Scholar]
- 137. Budenz DL, Rhee P, Feuer WJ et al. Sensitivity and specificity of the Swedish interactive threshold algorithm for glaucomatous visual field defects. Ophthalmology 2002; 109: 1052–1058. [DOI] [PubMed] [Google Scholar]
- 138. Kim JM, Kyung H, Shim SH et al. Location of initial visual field defects in glaucoma and their modes of deterioration. Invest Ophthalmol Vis Sci 2015; 56: 7956–7962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139. Drance SM. The glaucomatous visual field. Br J Ophthalmol 1972; 56: 186–200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140. Garway‐Heath DF, Poinoosawmy D, Fitzke FW et al. Mapping the visual field to the optic disc in normal tension glaucoma eyes. Ophthalmology 2000; 107: 1809–1815. [DOI] [PubMed] [Google Scholar]
- 141. Leite MT, Zangwill LM, Weinreb RN et al. Structure‐function relationships using the Cirrus spectral domain optical coherence tomograph and standard automated perimetry. J Glaucoma 2012; 21: 49–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142. FORUM Instructions for Use Software version 3.2. Germany: Carl Zeiss Meditec AG, 2013. [Google Scholar]
- 143. Katz BJ, Pomeranz HD. Visual field defects and retinal nerve fiber layer defects in eyes with buried optic nerve drusen. Am J Ophthamol 2006; 141: 248–253. [DOI] [PubMed] [Google Scholar]
- 144. Purvin V, Sundaram S, Kawasaki A. Neuroretinitis: review of the literature and new observations. J Neuroophthalmol 2011; 31: 58–68. [DOI] [PubMed] [Google Scholar]
- 145. Chiang J, Wong E, Whatham A et al. The usefulness of multimodal imaging for differentiating pseudopapilloedema and true swelling of the optic nerve head: a review and case series. Clin Exp Optom 2015; 98: 12–24. [DOI] [PubMed] [Google Scholar]
- 146. Zangerl B, Whatham A, Kim J et al. Reconciling visual field defects and retinal nerve fibre layer asymmetric patterns in retrograde degeneration: an extended case series. Clin Exp Optom 2017; 100: 214–226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147. Menjot de Champfleur N, Menjot de Champfleur S, Galanaud D et al. Imaging of the optic chiasm and retrochiasmal visual pathways. Diagn Interv Imaging 2013; 94: 957–971. [DOI] [PubMed] [Google Scholar]
- 148. Menjot de Champfleur N, Leboucq N, Menjot de Champfleur S et al. Imaging of the pre‐chiasmatic optic nerve. Diagn Interv Imaging 2013; 94: 973–984. [DOI] [PubMed] [Google Scholar]
- 149. Tantiwongkosi B, Salamon N. Imaging of retrochiasmal and higher cortical visual disorders. Neuroimaging Clin N Am 2015; 25: 411–424. [DOI] [PubMed] [Google Scholar]
- 150. Herse P. Pituitary macroadenoma: a case report and review. Clin Exp Optom 2014; 97: 125–132. [DOI] [PubMed] [Google Scholar]
- 151. Vuori ML, Mantyjarvi M. Tilted disc syndrome may mimic false visual field deterioration. Acta Ophthalmol 2008; 86: 622–625. [DOI] [PubMed] [Google Scholar]
- 152. Kupfer C, Chumbley L, Downer JC. Quantitative histology of optic nerve, optic tract and lateral geniculate nucleus of man. J Anat 1967; 101: 393–401. [PMC free article] [PubMed] [Google Scholar]
- 153. Kardon R, Kawasaki A, Miller NR. Origin of the relative afferent pupillary defect in optic tract lesions. Ophthalmology 2006; 113: 1345–1353. [DOI] [PubMed] [Google Scholar]
- 154. Kedar S, Zhang X, Lynn MJ et al. Congruency in homonymous hemianopia. Am J Ophthamol 2007; 143: 772–780. [DOI] [PubMed] [Google Scholar]
- 155. Zhang X, Kedar S, Lynn MJ et al. Homonymous hemianopias: clinical‐anatomic correlations in 904 cases. Neurology 2006; 66: 906–910. [DOI] [PubMed] [Google Scholar]
- 156. Jindahra P, Petrie A, Plant GT. The time course of retrograde trans‐synaptic degeneration following occipital lobe damage in humans. Brain 2012; 135: 534–541. [DOI] [PubMed] [Google Scholar]
- 157. Artes PH, Iwase A, Ohno Y et al. Properties of perimetric threshold estimates from Full Threshold, SITA Standard and SITA Fast strategies. Invest Ophthalmol Vis Sci 2002; 43: 2654–2659. [PubMed] [Google Scholar]
- 158. Spenceley SE, Henson DB. Visual field test simulation and error in threshold estimation. Br J Ophthalmol 1996; 80: 304–308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 159. Gillespie BW, Musch DC, Guire KE et al. The collaborative initial glaucoma treatment study: baseline visual field and test‐retest variability. Invest Ophthalmol Vis Sci 2003; 44: 2613–2620. [DOI] [PubMed] [Google Scholar]
- 160. Heijl A, Lindgren A, Lindgren G. Test‐retest variability in glaucomatous visual fields. Am J Ophthamol 1989; 108: 130–135. [DOI] [PubMed] [Google Scholar]
- 161. Heijl A, Bengtsson B, Chauhan BC et al. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients. Ophthalmology 2008; 115: 1557–1565. [DOI] [PubMed] [Google Scholar]
- 162. Chauhan BC, Garway‐Heath DF, Goni FJ et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol 2008; 92: 569–573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163. Nayak BK, Maskati QB, Parikh R. The unique problem of glaucoma: under‐diagnosis and over‐treatment. Indian J Ophthamol 2011; 59 (Suppl): S1‐S2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164. Ohba N, Nakao K, Isashiki Y et al. The 100 most frequently cited articles in ophthalmology journals. Arch Ophthalmol 2007; 125: 952–960. [DOI] [PubMed] [Google Scholar]
- 165. Harwerth RS, Carter‐Dawson L, Shen F et al. Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest Ophthalmol Vis Sci 1999; 40: 2242–2250. [PubMed] [Google Scholar]
- 166. Johnson CA, Keltner JL, Cello KE et al. Baseline visual field characteristics in the Ocular Hypertension Treatment Study. Ophthalmology 2002; 109: 432–437. [DOI] [PubMed] [Google Scholar]
- 167. Miglior S, Zeyen T, Pfeiffer N et al. The European glaucoma prevention study design and baseline description of the participants. Ophthalmology 2002; 109: 1612–1621. [DOI] [PubMed] [Google Scholar]
- 168. Leske MC, Heijl A, Hyman L et al. Early Manifest Glaucoma Trial: design and baseline data. Ophthalmology 1999; 106: 2144–2153. [DOI] [PubMed] [Google Scholar]
- 169. Bowd C, Zangwill LM, Berry CC et al. Detecting early glaucoma by assessment of retinal nerve fiber layer thickness and visual function. Invest Ophthalmol Vis Sci 2001; 42: 1993–2003. [PubMed] [Google Scholar]
- 170. Harwerth RS, Quigley HA. Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch Ophthalmol 2006; 124: 853–859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 171. Spry PG, Johnson CA, Mansberger SL et al. Psychophysical investigation of ganglion cell loss in early glaucoma. J Glaucoma 2005; 14: 11–19. [DOI] [PubMed] [Google Scholar]
- 172. Phu J, Khuu SK, Zangerl B et al. A comparison of Goldmann III, V and spatially equated test stimuli in visual field testing: the importance of complete and partial spatial summation. Ophthalmic Physiol Opt 2017; 37: 160–176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 173. Wall M, Doyle CK, Eden T et al. Size threshold perimetry performs as well as conventional automated perimetry with stimulus sizes III, V and VI for glaucomatous loss. Invest Ophthalmol Vis Sci 2013; 54: 3975–3983. [DOI] [PubMed] [Google Scholar]
- 174. De Natale R, Marraffa M, Morbio R et al. Visual field defects and normal nerve fiber layer: may they coexist in primary open‐angle glaucoma? Ophthalmologica 2000; 214: 119–121. [DOI] [PubMed] [Google Scholar]
- 175. Giuffre G, Giammanco R, Dardanoni G et al. Prevalence of glaucoma and distribution of intraocular pressure in a population. The Casteldaccia Eye Study. Acta Ophthalmol Scand 1995; 73: 222–225. [DOI] [PubMed] [Google Scholar]
- 176. Bedggood P, Tanabe F, McKendrick AM et al. Automatic identification of the temporal retinal nerve fiber raphe from macular cube data. Biomed Opt Express 2016; 7: 4043–4053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 177. Ballae Ganeshrao S, Turpin A, Denniss J et al. Enhancing structure‐function correlations in glaucoma with customized spatial mapping. Ophthalmology 2015; 122: 1695–1705. [DOI] [PubMed] [Google Scholar]
- 178. Turpin A, Jankovic D, McKendrick A. Retesting visual fields: utilizing prior information to decrease test‐retest variability in glaucoma. Invest Ophthalmol Vis Sci 2007; 48: 1627–1634. [DOI] [PubMed] [Google Scholar]
- 179. Heijl A, Lindgren G, Olsson J. Normal variability of static perimetric threshold values across the central visual field. Arch Ophthalmol 1987; 105: 1544–1549. [DOI] [PubMed] [Google Scholar]
- 180. Russell RA, Garway‐Heath DF, Crabb DP. New insights into measurement variability in glaucomatous visual fields from computer modelling. PLoS ONE 2013; 8: e83595. [DOI] [PMC free article] [PubMed] [Google Scholar]